My WebLink
|
Help
|
About
|
Sign Out
Home
Browse
Search
75A - PH - MEDICAL MARIJUANA - PROHIBIT
Clerk
>
Agenda Packets / Staff Reports
>
City Council (2004 - Present)
>
2007
>
10/01/2007
>
75A - PH - MEDICAL MARIJUANA - PROHIBIT
Metadata
Thumbnails
Annotations
Entry Properties
Last modified
1/3/2012 4:37:35 PM
Creation date
9/26/2007 2:00:08 PM
Metadata
Fields
Template:
City Clerk
Doc Type
Agenda Packet
Item #
75A
Date
10/1/2007
Destruction Year
2012
There are no annotations on this page.
Document management portal powered by Laserfiche WebLink 9 © 1998-2015
Laserfiche.
All rights reserved.
/
168
PDF
Print
Pages to print
Enter page numbers and/or page ranges separated by commas. For example, 1,3,5-12.
After downloading, print the document using a PDF reader (e.g. Adobe Reader).
View images
View plain text
There are also ties linked to marijuana use and psychophrenia, not to mention the <br />short-term memory loss that can have an impact on learning and everyday tasks <br />such as driving, Bowlby said. The information, she said, has come from a number of <br />studies done throughout North America. In recent years, it's also been teamed marijuana <br />has more THC (a chemical i.n pot) in it than it had in the past. "That will change what it <br />does in someone's body," Bowlby said. <br />While Bowlby stressed pot may not be a gateway drug for everyone, it has been <br />shown the younger a person starts snicking weed, the more likely he or she is to <br />become addicted to it or move on to other drugs, <br />Source: http•//www whitehorsestar cony/auth.php`?r=45899 <br />National: <br />In Their Words: What the Experts Say: <br />The American Academy of Ophthalmology: <br />"Based on reviews by the National. Eye Institute (NEI) and the Institute of Medicine and <br />on available scientific evidence, the Task Force on Complementary Therapies believes <br />that no scientif.c evidence has been found that demonstrates increased benefits and/or <br />diminished risks of marijuana use to treat glaucoma compared with the wide variety of <br />pharmaceutical agents now available." <br />Complementary Therapy Assessment: Marijuana in the Treatment of Glaucoma, <br />American Academy of Ophth.ahnology, M.ay 2003 <br />The American Medical Association: <br />"...AMA. recommends that marijuana be retailed in Schedule I of the Controlled <br />Substances Act...AMA believes that the NIH should use its resources and influence to <br />support the development of a simoke-free inhaled delivery system for marijuana or delta- <br />9-tetrahydrocannabinol (THC) to reduce the health hazards associated. with the <br />combustion and inhalation of marijuana..." <br />Policy Statement H-95.952, American Medical Association, http•//www.ama-assn.or~ <br />The National Multiple Sclerosis Society: <br />"Studies completed thus far have not provided convincing evidence that marijuana or its <br />derivatives provide substantiated benefits fox symptoms of MS." <br />The M.S :Information Sourcebook, Marijuana (Cannabis), National Multiple Sclerosis <br />Society, September 18th, 2006 <br />The Institute of Medicine (TOM): <br />"Because of the health risks associated. with smoking, smoked marijuana should generally <br />not be recommended for long term medical use." <br />Marijuana and Medicine: Assessing the Science Base, Institute of Medicine, 1999 <br />Source: http•//www wlvtehousedrugpolicy aov/druufactJfactSht/medical mariiuana.h.tml <br />21 <br />75A-116 <br />
The URL can be used to link to this page
Your browser does not support the video tag.